🇺🇸 FDA

Drug profile · INN

methscopolamine bromide

METHSCOPOLAMINE BROMIDE

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

methscopolamine bromide (METHSCOPOLAMINE BROMIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN methscopolamine bromide
Brand METHSCOPOLAMINE BROMIDE
Route ORAL
Formulation TABLET

Related patents

Search patents →

  1. US 12162861

    Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12145922

    Selective D3 dopamine receptor agonists and methods of their use

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12102640

    Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12097196

    Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11634404

    Selective D3 dopamine receptor agonists and methods of their use

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11337971

    Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

    Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11299476

    Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11261461

    Methods and compositions for selective generation of dopaminergic precursors

    Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is methscopolamine bromide?

methscopolamine bromide (METHSCOPOLAMINE BROMIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for methscopolamine bromide?

METHSCOPOLAMINE BROMIDE is a marketed brand name for methscopolamine bromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of methscopolamine bromide?

methscopolamine bromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.